Biofrontera Q2 FY26 net loss narrows to $0.6 million; revenue rises 32.9% to $12 million - BFRI News | RalliesBiofrontera Q2 FY26 net loss narrows to $0.6 million; revenue rises 32.9% to $12 million
B
BFRI• First-half results
- First-half net product revenue increased 25.4% to USD 22.09 million; GAAP net loss narrowed to USD 5.36 million.
Q2 revenue and margin improve
- Biofrontera Q2 2026 net product revenue rose 32.9% to USD 12 million; gross margin widened 9.2 percentage points to 80%.
- GAAP net loss narrowed to USD 604,000, or USD 0.05 per share, from USD 5.3 million a year earlier.
- Non-GAAP adjusted EBITDA improved to a loss of USD 170,000 from a loss of USD 5.14 million in the prior-year quarter.
Management update on RhodoLED XL lamp
- Management flagged an ITC exclusion order on the RhodoLED XL lamp that pulled forward some orders; the company is pursuing a modified XL lamp.
ODYS
•
